Skip to content
← Full study record

NCT01678443 · MORE INFO

Limitations, agreements, and source contact

Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies · Source last updated 2021-04-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
This study was closed when replaced by a new study adding chemotherapy to this regimen
point Of Contact
email
agopal@u.washington.edu
organization
Fred Hutchinson Cancer Research Center
phone
206-288-2037
title
Ajay K. Gopal, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
This study was closed when replaced by a new study adding chemotherapy to this regimen
point Of Contact
email
agopal@u.washington.edu
organization
Fred Hutchinson Cancer Research Center
phone
206-288-2037
title
Ajay K. Gopal, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice